母亲肥胖中胎盘miRNA失调与产前及产后生长相关
该研究对70名孕妇(20例孕前超重/肥胖、25例妊娠期肥胖、25例对照)的胎盘miRNA进行检测,发现8种miRNA在肥胖组胎盘中降低,其中4种与母亲代谢参数相关并可预测较低出生体重和产后体重增长增加,提示这些miRNA可能是产前及产后生长的早期标志物。
要点
- 孕前超重/肥胖或妊娠期肥胖孕妇胎盘中8种miRNA表达降低(均P<0.05)。
- miR-100、miR-1285、miR-296和miR-487可预测较低出生体重(R2>30%)和产后体重增长增加(R2>20%)。
- miR-296也存在于血浆中,并与胎盘表达及产前产后生长参数相关(均P<0.05)。
核心结论
- 母亲肥胖中存在特定的胎盘miRNA表达谱,失调的胎盘miRNA可能介导母亲肥胖对子代的促生长效应,并可作为产前及产后生长的早期标志物。
研究设计与样本
- 研究纳入70名孕妇,其中孕前超重/肥胖(preOB)20例、妊娠期肥胖(gestOB)25例、对照25例,采用TaqMan低密度阵列和实时聚合酶链反应检测胎盘miRNA表达。
- 分娩时称量胎盘和新生儿体重,并在婴儿1、4、12月龄时称重。
主要发现
- 孕前超重/肥胖或妊娠期肥胖组胎盘中8种miRNA(miR-100、miR-1269、miR-1285、miR-181、miR-185、miR-214、miR-296和miR-487)表达降低(均P<0.05)。
- 其中miR-100、miR-1285、miR-296和miR-487与母亲代谢参数相关(均P<0.05),并可预测较低出生体重(均P<0.05;R2>30%)和产后体重增长增加(均P<0.05;R2>20%)。
- 生物信息学分析显示这些miRNA与细胞增殖和胰岛素信号通路相关。
- miR-296也存在于血浆样本中,并与胎盘表达及产前和产后生长参数相关(均P<0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Human placenta exhibits a specific microRNA (miRNA) expression pattern. Some of these miRNAs are dysregulated in pregnancy disorders such as preeclampsia and intrauterine growth restriction and are potential biomarkers for these pathologies. OBJECTIVE: To study the placental miRNA profile in pregnant women with pregestational overweight/obesity (preOB) or gestational obesity (gestOB) and explore the associations between placental miRNAs dysregulated in maternal obesity and prenatal and postnatal growth. METHODS: TaqMan Low Density Arrays and real-time polymerase chain reaction were used to profile the placental miRNAs in 70 pregnant women (20 preOB, 25 gestOB, and 25 control). Placentas and newborns were weighed at delivery, and infants were weighed at 1, 4, and 12 months of age. RESULTS: Eight miRNAs were decreased in placentas from preOB or gestOB (miR-100, miR-1269, miR-1285, miR-181, miR-185, miR-214, miR-296, and miR-487) (all P < 0.05). Among them, miR-100, miR-1285, miR-296, and miR-487 were associated with maternal metabolic parameters (all P < 0.05) and were predictors of lower birth weight (all P < 0.05; R2 > 30%) and increased postnatal weight gain (all P < 0.05; R2 > 20%). In silico analysis showed that these miRNAs were related to cell proliferation and insulin signaling pathways. miR-296 was also present in plasma samples and associated with placental expression and prenatal and postnatal growth parameters (all P < 0.05). CONCLUSIONS: We identified a specific placental miRNA profile in maternal obesity. Placental miRNAs dysregulated in maternal obesity may be involved in mediation of growth-promoting effects of maternal obesity on offspring and could be used as early markers of prenatal and postnatal growth.
引用
- Carreras-Badosa G, Bonmatí A, Ortega FJ, et al. Dysregulation of Placental miRNA in Maternal Obesity Is Associated With Pre- and Postnatal Growth. J Clin Endocrinol Metab. 2017. PMID: 28368446. doi:10.1210/jc.2017-00089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。